Medical Oncology

Prof. Dr. Özkan Kanat

Doctor and researcher Acıbadem Bursa Hastanesi Bursa
Breast NeoplasmsLung NeoplasmsStomach NeoplasmsGastrointestinal NeoplasmsNeoplasmsCarcinoma, Small CellAnemiaColorectal NeoplasmsBone NeoplasmsGranular Cell TumorAdenocarcinomaNeoplasms, Multiple PrimaryCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsUrinary Bladder Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 5 publications
  • Stomach Neoplasms 5 publications
  • Gastrointestinal Neoplasms 4 publications
  • Neoplasms 3 publications
  • Carcinoma, Small Cell 3 publications
  • Anemia 2 publications
  • Colorectal Neoplasms 2 publications
  • Bone Neoplasms 2 publications
  • Granular Cell Tumor 2 publications
  • Adenocarcinoma 2 publications
  • Neoplasms, Multiple Primary 2 publications
  • Carcinoma, Non-Small-Cell Lung 2 publications
  • Pancreatic Neoplasms 2 publications
  • Urinary Bladder Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Yumurtalık (Over) Kanseri
  • Prostat Kanseri
  • Pankreas Kanseri
  • Mide Kanseri
  • Meme Kanseri
  • Erkeklerde Meme Kanseri
  • Endometrial Kanser
  • Kolorektal Kanserler (Kolon ve Rektum Kanseri)
  • Böbrek Üstü Bezi Kanseri
  • Böbrek Kanseri
  • Anal (Makat) Kanseri
  • Akciğer, Akciğer Zarı Kanserleri (Mezotelyoma) ve Diğer Torasik Kanserler
  • Malign Melanom ve Diğer Deri Tümörleri
  • Kolon (Kalın Bağırsak) Kanseri
  • Akciğer Kanseri

CV

Education and experience

From source

Experience

  • 2019Acıbadem Sağlık Grubuacibadem.com.tr
  • 2012Vall d'Hebron Institute of Oncology Gastrointestinal and Phase I units / Barselona (Prof. Joseph Tabernero ile birlikte)acibadem.com.tr
  • 2011Fox Chase Cancer Center Philadelphia Externship Organizationacibadem.com.tr
  • 2011The University of North Carolina at Chapel Hill Cancer Hospital / Gastrointestinal Cancer Unit (Prof. Bert O?Neil ve Prof. Richard Goldberg ile birlikte)acibadem.com.tr
  • 2011Memorial Sloan Kettering Cancer Center / Gastrointestinal Cancer Unit (Prof. Nancy Kemeny ile birlikte) / New York, Amerika Birleşik Devletleriacibadem.com.tr
  • 1995 - 2019Uludağ Üniversitesi Tıp Fakültesi İç Hastalıkları ABD / Tıbbi Onkoloji Bilim Dalıacibadem.com.tr

Education

  • 2013Uludağ Üniversitesi / Farmakoloji / Doktora, Digeracibadem.com.tr
  • 2001Uludağ Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2000Uludağ Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 1995Ondokuzmayıs Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • InstitutionAcıbadem Bursa Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 5 publications · Model version —From source
  • Publications74 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:04https://www.acibadem.com.tr/doktor/ozkan-kanat/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

74 publications

  1. Retrospective Evaluation of Demographic and Clinical Features of Gastrointestinal Stromal Tumors

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.1864352 Source: OpenAlex

  2. DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer

    Genetic Testing and Molecular Biomarkers, 2021

    DOI 10.1089/gtmb.2020.0285 PMID 33877893 3 citations (Europe PMC) Source: OpenAlex

  3. MikroRNA-106a’nın Yüksek Ekspresyonu Kolorektal Kanserlerde Mikrosatellit İnstablite Durumu ile İlişkilidir

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2021

    DOI 10.32708/uutfd.917784 Source: OpenAlex

  4. Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations

    World Journal of Gastrointestinal Oncology, 2020

    DOI 10.4251/wjgo.v12.i10.1080 PMID 33133378 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Randomized controlled trial of 8 weeks’ vs 12 weeks’ interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer

    Colorectal Disease, 2019

    DOI 10.1111/codi.14867 PMID 31566843 37 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy

    World Journal of Clinical Oncology, 2019

    DOI 10.5306/wjco.v10.i2.52 PMID 30815371 14 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Shattering the castle walls: Anti-stromal therapy for pancreatic cancer

    World Journal of Gastrointestinal Oncology, 2018

    DOI 10.4251/wjgo.v10.i8.202 PMID 30147846 28 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics

    Annals of Oncology, 2018

    DOI 10.1093/annonc/mdy047.079 Source: OpenAlex

  9. Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status

    World Journal of Clinical Cases, 2018

    DOI 10.12998/wjcc.v6.i11.418 PMID 30294606 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Platinum-induced neurotoxicity: A review of possible mechanisms

    World Journal of Clinical Oncology, 2017

    DOI 10.5306/wjco.v8.i4.329 PMID 28848699 125 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 74 publications